Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LX compared with CSTL: revenue, margins and what each company keeps, and the suppliers and customers both name
LX
LexinFintech Holdings Ltd.
Change
Mkt cap
Revenue
Revenue
CSTL
Castle Biosciences Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
LX
LexinFintech Holdings Ltd.
vs
CSTL
Castle Biosciences Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
LX: latest quarter not drawable. CSTL: latest quarter is a loss; flow not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LX, solid
CSTL, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only LX
1
—
Institutional Funding Partner A
unlisted
supplier
Shared
0
No shared counterparties.
Only CSTL
13
—
Medicare
unlisted
customer
TMO
ThermoFisher Scientific
supplier
QGEN
Qiagen
supplier
—
The Washington University in St. Louis, Missouri (WUSTL)
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
unlisted
supplier
9 more · CSTL chain
›
LX
LexinFintech Holdings Ltd.
Change
0.60
▼
−5.54%
· post 0.60
Mkt cap
$101.9M
Revenue
—
Revenue
—
CSTL
Castle Biosciences Inc
Change
38.47
▼
−0.11%
· post 37.13
Closed
Oct 30 '26
Mkt cap
$1.1B
Revenue
$104M
Q2 FY26
Revenue
$344M
FY25
vs
Compare
Closed
Oct 30 '26
LX
LexinFintech Holdings Ltd.
vs
CSTL
Castle Biosciences Inc
0.60
▼
−5.54%
post 0.60
Price
38.47
▼
−0.11%
post 37.13
$101.9M
Mkt cap
$1.1B
—
Revenue
$104M
Q2 FY26
—
Revenue
$344M
FY25
Change
Change
LX
0.60
▼
−5.54%
vs
CSTL
38.47
▼
−0.11%
Closed
Oct 30 '26